With that currently being said, devoid of human trials there is absolutely no way to really evaluate how much YK11 can inhibit Myostatin in humans (if in any respect), and if there is a dosage that would equate to the same level of Myostatin inhibition that a genetic anomaly using a gene mutation has.We know this isn’t an genuine side result, but